TNFAIP3 and myeloid sarcoma: We also demonstrated a negative correlation between the TNFAIP3 gene expression level and the clinical parameters such as the relapse rate and Expanded Disability Status Scale (EDSS) score, indicating that the most aggressive forms of MS are characterized by lower level of TNFAIP3 expression [13].